Clinical Trials

NCT05199285 | TERMINATED | PHASE2
15 participants

A Phase II Study of Nivolumab + Ipilimumab in Advanced HCC Patients Who Have Progressed on First Line Atezolizumab + Bevacizumab

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-04
Start Date:
2023-01-19
Completion:
2026-02-01
Conditions
  • BCLC Stage B Hepatocellular Carcinoma
  • BCLC Stage C Hepatocellular Carcinoma
  • Locally Advanced Hepatocellular Carcinoma
  • Metastatic Hepatocellular Carcinoma
  • Stage III Hepatocellular Carcinoma AJCC v8
  • Stage IIIA Hepatocellular Carcinoma AJCC v8
  • Stage IIIB Hepatocellular Carcinoma AJCC v8
  • Stage IV Hepatocellular Carcinoma AJCC v8
  • Stage IVA Hepatocellular Carcinoma AJCC v8
  • Stage IVB Hepatocellular Carcinoma AJCC v8
  • Unresectable Hepatocellular Carcinoma
Interventions
  • BIOLOGICAL
No Results Yet
NCT05168163 | RECRUITING | PHASE2
122 participants

Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-04
Start Date:
2022-05-27
Completion:
2026-06-30
Conditions
  • Locally Advanced Hepatocellular Carcinoma
  • Metastatic Hepatocellular Carcinoma
  • Stage III Hepatocellular Carcinoma AJCC v8
  • Stage IIIA Hepatocellular Carcinoma AJCC v8
  • Stage IIIB Hepatocellular Carcinoma AJCC v8
  • Stage IV Hepatocellular Carcinoma AJCC v8
  • Stage IVA Hepatocellular Carcinoma AJCC v8
  • Stage IVB Hepatocellular Carcinoma AJCC v8
  • Unresectable Hepatocellular Carcinoma
Interventions
  • BIOLOGICAL
  • DRUG
No Results Yet
NCT05111574 | ACTIVE_NOT_RECRUITING | PHASE2
101 participants

Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-04
Start Date:
2022-08-11
Completion:
2027-07-15
Conditions
  • Anal Melanoma
  • Bladder Melanoma
  • Cervical Melanoma
  • Esophageal Melanoma
  • Gallbladder Melanoma
  • Head and Neck Mucosal Melanoma
  • Mucosal Melanoma
  • Nasopharyngeal Mucosal Melanoma
  • Oral Cavity Mucosal Melanoma
  • Penile Mucosal Melanoma
  • Rectal Melanoma
  • Recurrent Mucosal Melanoma
  • Sinonasal Mucosal Melanoma
  • Urethral Melanoma
  • Urinary System Mucosal Melanoma
  • Vaginal Melanoma
  • Vulvar Melanoma
Interventions
  • PROCEDURE
  • BIOLOGICAL
  • DRUG
No Results Yet
NCT05080166 | COMPLETED | NA
74 participants

UPLYFT For Lymphoma Survivors

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-04
Start Date:
2022-02-08
Completion:
2026-07-17
Conditions
  • Lymphoma
  • Survivorship
Interventions
  • OTHER
  • BEHAVIORAL
No Results Yet
NCT04969926 | RECRUITING
3000 participants

Natural History Study of Parathyroid Disorders

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-04
Start Date:
2021-11-30
Completion:
2031-01-22
Conditions
  • Parathyroid Cancer
  • Primary Hyperparathyroidism
  • Pseudohypoparathyroidism
  • Inheritable Bone Diseases
  • Multiple Endocrine Neoplasia, Type 1
No Results Yet
NCT04949100 | ACTIVE_NOT_RECRUITING | NA
50 participants

Microcurrent for Fibromyalgia

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-04
Start Date:
2021-10-25
Completion:
2026-12-31
Conditions
  • Fibromyalgia
Interventions
  • DEVICE
No Results Yet
NCT04943861 | RECRUITING | NA
200 participants

Human Immunodeficiency Virus (HIV) Food Insecurities

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-04
Start Date:
2023-12-01
Completion:
2027-02-28
Conditions
  • Food Insecurities
  • Cardiometabolic Comorbidities
  • HIV
  • PreDiabetes
  • Type 2 Diabetes Mellitus (T2DM)
Interventions
  • BEHAVIORAL
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page